Literature DB >> 29335658

Highly Stereoselective Asymmetric Aldol Routes to tert-Butyl-2-(3,5-difluorophenyl)-1-oxiran-2-yl)ethyl)carbamates: Building Blocks for Novel Protease Inhibitors.

Arun K Ghosh1, Emilio L Cárdenas1, Margherita Brindisi1.   

Abstract

Enantioselective syntheses of tert-butyl ((S)-2-(3,5-difluorophenyl)-1-((S)-oxiran-2-yl)ethyl)carbamate and ((S)-2-(3,5-difluorophenyl)-1-((R)-oxiran-2-yl)ethyl)carbamate are described. We utilized asymmetric syn- and anti-aldol reactions to set both stereogenic centers. We investigated ester-derived Ti-enolate aldol reactions as well as Evans' diastereoselective syn-aldol reaction for these syntheses. We have converted optically active ((S)-2-(3,5-difluorophenyl)-1-((S)-oxiran-2-yl)ethyl)carbamate to a potent β-secretase inhibitor.

Entities:  

Keywords:  Aldol reaction; Asymmetric; Fluoroisostere; Protease Inhibitor; Stereoselective

Year:  2017        PMID: 29335658      PMCID: PMC5765997          DOI: 10.1016/j.tetlet.2017.09.025

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  20 in total

Review 1.  Developing β-secretase inhibitors for treatment of Alzheimer's disease.

Authors:  Arun K Ghosh; Margherita Brindisi; Jordan Tang
Journal:  J Neurochem       Date:  2011-11-28       Impact factor: 5.372

2.  Synthesis of a C-terminally biotinylated macrocyclic peptide mimetic exhibiting high Grb2 SH2 domain-binding affinity.

Authors:  Zhen-Dan Shi; Hongpeng Liu; Manchao Zhang; Karen M Worthy; Lakshman Bindu; Dajun Yang; Robert J Fisher; Terrence R Burke
Journal:  Bioorg Med Chem       Date:  2005-07-01       Impact factor: 3.641

Review 3.  Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics.

Authors:  Dennis J Selkoe; Dale Schenk
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-01-10       Impact factor: 13.820

4.  Prospects of β-Secretase Inhibitors for the Treatment of Alzheimer's Disease.

Authors:  Arun K Ghosh; Jordan Tang
Journal:  ChemMedChem       Date:  2015-07-03       Impact factor: 3.466

5.  Design, synthesis, and crystal structure of hydroxyethyl secondary amine-based peptidomimetic inhibitors of human beta-secretase.

Authors:  Michel C Maillard; Roy K Hom; Timothy E Benson; Joseph B Moon; Shumeye Mamo; Michael Bienkowski; Alfredo G Tomasselli; Danielle D Woods; D Bryan Prince; Donna J Paddock; Thomas L Emmons; John A Tucker; Michael S Dappen; Louis Brogley; Eugene D Thorsett; Nancy Jewett; Sukanto Sinha; Varghese John
Journal:  J Med Chem       Date:  2007-02-22       Impact factor: 7.446

6.  Transition-State Mimetics for HIV Protease Inhibitors: Stereocontrolled Synthesis of Hydroxyethylene and Hydroxyethylamine Isosteres by Ester-Derived Titanium Enolate Syn and Anti-Aldol Reactions.

Authors:  Arun K. Ghosh; Steve Fidanze
Journal:  J Org Chem       Date:  1998-09-04       Impact factor: 4.354

Review 7.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

8.  Solid-phase synthesis of HTLV-1 protease inhibitors containing hydroxyethylamine dipeptide isostere.

Authors:  Kenichi Akaji; Kenta Teruya; Saburo Aimoto
Journal:  J Org Chem       Date:  2003-06-13       Impact factor: 4.354

Review 9.  BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease.

Authors:  Arun K Ghosh; Heather L Osswald
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

10.  BACE1 inhibitor drugs in clinical trials for Alzheimer's disease.

Authors:  Robert Vassar
Journal:  Alzheimers Res Ther       Date:  2014-12-24       Impact factor: 6.982

View more
  2 in total

1.  Nature Inspired Molecular Design: Stereoselective Synthesis of Bicyclic and Polycyclic Ethers for Potent HIV-1 Protease Inhibitors.

Authors:  Arun K Ghosh; Margherita Brindisi
Journal:  Asian J Org Chem       Date:  2018-06-08       Impact factor: 3.319

Review 2.  The Curtius Rearrangement: Applications in Modern Drug Discovery and Medicinal Chemistry.

Authors:  Arun K Ghosh; Margherita Brindisi; Anindya Sarkar
Journal:  ChemMedChem       Date:  2018-10-11       Impact factor: 3.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.